Synbiotic compound preparation conducive to alleviation of hypertension symptoms without solid lesions and preparation method of synbiotic compound preparation

A compound preparation and a technology of synbiotics are applied in the field of preparation of synbiotic compound preparations to achieve the effects of improving the symptoms of hypertension without substantial lesions, ensuring survival, and improving nutritional value.

Inactive Publication Date: 2019-03-08
江苏宏众百德生物科技有限公司
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the single use of probiotics and prebiotics has different mechanisms for their respective functions, and different individuals will show di

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synbiotic compound preparation conducive to alleviation of hypertension symptoms without solid lesions and preparation method of synbiotic compound preparation

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0025] Example one

[0026] The present invention provides a technical solution: a synbiotic compound preparation that helps relieve hypertension symptoms without substantial lesions, and the formula of the synbiotic compound preparation that helps relieve hypertension symptoms without substantial lesions includes the following components : Including Bifidobacterium infantis 8%, Bifidobacterium longum 8%, Bifidobacterium breve 8%, Lactobacillus acidophilus 3%, Lactobacillus casei 3%, Lactobacillus rhamnosus 3%, Lactobacillus plantarum 3%, Lactobacillus paracasei 3%, Lactobacillus bulgaricus 3%, Streptococcus thermophilus 12%, sodium acetate 0.2%, sodium butyrate 0.4%, oligofructose 1.2%, lactulose 0.5%, barley malt powder 0.1%, skimmed sheep Milk powder 1.4%, active hexose related compounds 1.3%, inulin 0.8%, plantain husk 0.2%.

[0027] Among them, the number of Bifidobacterium infantis is 1222, the number of Bifidobacterium longum is CCM 7952, the number of Bifidobacterium breve...

Example Embodiment

[0035] Example two

[0036] The present invention provides a technical solution: a synbiotic compound preparation that helps relieve hypertension symptoms without substantial lesions, and the formula of the synbiotic compound preparation that helps relieve hypertension symptoms without substantial lesions includes the following components : Including Bifidobacterium infantis 9%, Bifidobacterium longum 9%, Bifidobacterium breve 9%, Lactobacillus acidophilus 4%, Lactobacillus casei 4%, Lactobacillus rhamnosus 4%, Lactobacillus plantarum 4%, Lactobacillus paracasei 4%, Lactobacillus bulgaricus 4%, Streptococcus thermophilus 13%, sodium acetate 0.3%, sodium butyrate 0.5%, oligofructose 1.3%, lactulose 0.6%, barley malt powder 0.2%, skimmed sheep Milk powder 1.5%, active hexose related compounds 1.4%, inulin 0.9%, and plantain husk 0.3%.

[0037] Among them, Bifidobacterium infantis is numbered 1222, Bifidobacterium longum is numbered CCM 7952, Bifidobacterium breve is numbered M-16V, ...

Example Embodiment

[0045] Example three

[0046] The present invention provides a technical solution: a synbiotic compound preparation that helps relieve hypertension symptoms without substantial lesions, and the formula of the synbiotic compound preparation that helps relieve hypertension symptoms without substantial lesions includes the following components : Including Bifidobacterium infantis 10%, Bifidobacterium longum 10%, Bifidobacterium breve 10%, Lactobacillus acidophilus 5%, Lactobacillus casei 5%, Lactobacillus rhamnosus 5%, Lactobacillus plantarum 5%, Lactobacillus paracasei 5%, Lactobacillus bulgaricus 5%, Streptococcus thermophilus 14%, sodium acetate 0.4%, sodium butyrate 0.6%, oligofructose 1.4%, lactulose 0.7%, barley malt powder 0.3%, skim sheep Milk powder 1.6%, active hexose related compounds 1.5%, inulin 1%, and plantain husk 0.4%.

[0047] Among them, Bifidobacterium infantis is numbered 1222, Bifidobacterium longum is numbered CCM 7952, Bifidobacterium breve is numbered M-16V, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a synbiotic compound preparation conducive to alleviation of hypertension symptoms without solid lesions. A formula of the synbiotic compound preparation comprises 8%-12% of bifidobacterium infantis, 8%-12% of bifidobacterium longum, 8%-12% of bifidobacterium breve, 3%-6% of lactobacillus acidophilus, 3%-6% of lactobacillus casei, 3%-6% of lactobacillus rhamnosus, 3%-6% oflactobacillus plantarum, 3%-6% of lactobacillus paracasei, 3%-6% of lactobacillus bulgaricus, 12%-18% of streptococcus thermophilus, 0.2%-0.8% of sodium acetate, 0.4-0.8% of sodium butyrate, 1.2%-1.5%of fructo-oligosaccharide, 0.5%-0.9% of lactulose, 0.1%-0.5% of barley malt powder, 1.4%-1.8% of skim sheep milk powder, 1.3%-1.8% of active hexose correlated compound, 0.8%-1.4% of inulin and 0.2%-0.5% of plantago ovate shell. The invention further discloses a preparation method of the synbiotic compound preparation conducive to alleviation of hypertension symptoms without solid lesions. The preparation method includes steps of quantitative weighing, probiotic culture, probiotic fermentation, skim sheep milk resuspension and mixing for capsule preparation.

Description

technical field [0001] The invention relates to the technical field of preparation of synbiotic compound preparations, in particular to a synbiotic compound preparation and a preparation method thereof which are helpful for alleviating the symptoms of hypertension without substantial lesions. Background technique [0002] Hypertension refers to an increase in systemic arterial blood pressure (systolic blood pressure and / or diastolic blood pressure) as the main feature (systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg), which may be accompanied by heart, brain, kidney and other organ functions Or clinical syndrome of organic damage. Hypertension is the most common chronic disease and the main risk factor for cardiovascular and cerebrovascular diseases. Patients with hypertension are often accompanied by disorders of fat and glucose metabolism, as well as functional or organic changes in organs such as the heart, brain, kidney, and retina. Clinically,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8998A61K9/48A61P9/12A23C9/152A61K35/747A61K35/745A61K35/744A61K35/20A61K31/733A61K31/702A61K31/7016A61K31/7004A61K31/19
CPCA23C9/152A61K9/48A61K31/19A61K31/7004A61K31/7016A61K31/702A61K31/733A61K35/20A61K35/744A61K35/745A61K35/747A61K36/68A61K36/8998A61P9/12A61K2300/00
Inventor 张军毅李东尧单锴周克茹
Owner 江苏宏众百德生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap